Investing
Nvidia Corp. officially joined vaunted company Tuesday, becoming just the seventh public U.S. company to finish a trading session in $1 trillion territory. The...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
U.S. natural-gas supplies in storage marked their biggest weekly decline in nearly three years — but that wasn’t enough to rally prices for the...
Investing
Oil futures rose Thursday to settle at their highest prices since late November after government data showed larger-than-anticipated drops in U.S. crude inventories and...
Investing
Oil prices gave up early losses to finish higher on Friday — with production outages in the U.S., strong economic data and concerns about...
Investing
Oil futures fell Monday, pulling global benchmark Brent crude prices down to their lowest finish since December 2021, with the outlook for energy demand...
Investing
Gold prices settled lower on Monday, after posting a gain last week, as traders awaited a Tuesday inflation report followed by the conclusion of...
Investing
By Denny Jacob Lockheed Martin and GlobalFoundries on Monday said they would collaborate to advance domestic semiconductor manufacturing. The defense company said its collaboration...
Investing
By Chris Wack NeuroOne Medical Technologies shares were up 4.9% to $1.29 after the company said it submitted a 510(k) application to the U.S....
Investing
Key takeaways Over 7,000 subreddits have closed in protest of Reddit’s new API charges CEO Steve Huffman has defended the move, saying generative AI...
Investing
By Chris Wack Marker Therapeutics shares were up 19% to $2.98 after the company said the first patient has been treated in its Phase...
Investing
Few folks know it, but there’s a way to tap the surging AI trend for a growing 10% dividend. Better still, this monster “AI-powered...
Investing
By Josh Beckerman Disc Medicine shares added to Friday’s gains, rising 8% to $49.20 on Monday as more analysts raised price targets following news...
Investing
By Chris Wack Genelux shares were up 12% to $31.17 on Monday after the late-stage clinical-stage immuno-oncology company priced a private placement for 900,000...
